My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 98

    1.

    Metabolic and immunological features of the failing islet-transplanted patient.

    Fiorina P, Vergani A, Petrelli A, D'Addio F, Monti L, Abdi R, Bosi E, Maffi P, Secchi A.

    Diabetes Care. 2008 Mar;31(3):436-8. Epub 2007 Dec 10.PMID: 18071001 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Islet transplantation is associated with an improvement of cardiovascular function in type 1 diabetic kidney transplant patients.

    Fiorina P, Gremizzi C, Maffi P, Caldara R, Tavano D, Monti L, Socci C, Folli F, Fazio F, Astorri E, Del Maschio A, Secchi A.

    Diabetes Care. 2005 Jun;28(6):1358-65.PMID: 15920052 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Pathology of an islet transplant 2 years after transplantation: evidence for a nonimmunological loss.

    Smith RN, Kent SC, Nagle J, Selig M, Iafrate AJ, Najafian N, Hafler DA, Auchincloss H, Orban T, Cagliero E.

    Transplantation. 2008 Jul 15;86(1):54-62.PMID: 18622278 [PubMed - indexed for MEDLINE]Related articles

    4.

    Assessment of cytotoxic lymphocyte gene expression in the peripheral blood of human islet allograft recipients: elevation precedes clinical evidence of rejection.

    Han D, Xu X, Baidal D, Leith J, Ricordi C, Alejandro R, Kenyon NS.

    Diabetes. 2004 Sep;53(9):2281-90.PMID: 15331537 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Monotherapy with anti-LFA-1 monoclonal antibody promotes long-term survival of rat islet xenografts.

    Tredget EB, Arefanian H, Gill RG, Rajotte RV, Rayat GR.

    Cell Transplant. 2008;17(6):599-608.PMID: 18819248 [PubMed - indexed for MEDLINE]Related articles

    6.

    The caspase selective inhibitor EP1013 augments human islet graft function and longevity in marginal mass islet transplantation in mice.

    Emamaullee JA, Davis J, Pawlick R, Toso C, Merani S, Cai SX, Tseng B, Shapiro AM.

    Diabetes. 2008 Jun;57(6):1556-66. Epub 2008 Mar 20.PMID: 18356409 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Activated effector and memory T cells contribute to circulating sCD30: potential marker for islet allograft rejection.

    Saini D, Ramachandran S, Nataraju A, Benshoff N, Liu W, Desai N, Chapman W, Mohanakumar T.

    Am J Transplant. 2008 Sep;8(9):1798-808.PMID: 18786226 [PubMed - indexed for MEDLINE]Related articles

    8.

    Adenoviral-mediated overexpression of either membrane-bound human FasL or human decoy Fas can prolong pig islet xenograft survival in a rat transplant model.

    Kawamoto K, Tanemura M, Saga A, Komoda H, Fumimoto Y, Deguchi T, Machida T, Sawa Y, Nishida T, Ito T.

    Transplant Proc. 2008 Mar;40(2):477-9.PMID: 18374107 [PubMed - indexed for MEDLINE]Related articles

    9.

    Immunology of pancreatic islet transplantation.

    Reffet S, Thivolet C.

    Diabetes Metab. 2006 Dec;32(5 Pt 2):523-6. Review.PMID: 17130811 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Pig islet xenograft rejection in a mouse model with an established human immune system.

    Tonomura N, Shimizu A, Wang S, Yamada K, Tchipashvili V, Weir GC, Yang YG.

    Xenotransplantation. 2008 Mar;15(2):129-35.PMID: 18447886 [PubMed - indexed for MEDLINE]Related articles

    11.

    Overexpressed exogenous IL-4 And IL-10 paradoxically regulate allogenic T-cell and cardiac myocytes apoptosis through FAS/FASL pathway.

    Furukawa H, Oshima K, Tung T, Cui G, Laks H, Sen L.

    Transplantation. 2008 Feb 15;85(3):437-46.PMID: 18301335 [PubMed - indexed for MEDLINE]Related articles

    12.

    Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts.

    Gillard P, Ling Z, Mathieu C, Crenier L, Lannoo M, Maes B, Roep B, Gorus F, Pipeleers D, Keymeulen B.

    Transplantation. 2008 Jan 27;85(2):256-63.PMID: 18212631 [PubMed - indexed for MEDLINE]Related articles

    13.

    Viral IL-10 gene transfer prolongs rat islet allograft survival.

    Kim YH, Lim DG, Wee YM, Kim JH, Yun CO, Choi MY, Park YH, Kim SC, Han DJ.

    Cell Transplant. 2008;17(6):609-18.PMID: 18819249 [PubMed - indexed for MEDLINE]Related articles

    14.

    Metabolic aspects of pig-to-monkey (Macaca fascicularis) islet transplantation: implications for translation into clinical practice.

    Casu A, Bottino R, Balamurugan AN, Hara H, van der Windt DJ, Campanile N, Smetanka C, Cooper DK, Trucco M.

    Diabetologia. 2008 Jan;51(1):120-9. Epub 2007 Oct 25.PMID: 17960359 [PubMed - indexed for MEDLINE]Related articles

    15.

    Quantitative in vivo islet potency assay in normoglycemic nude mice correlates with primary graft function after clinical transplantation.

    Caiazzo R, Gmyr V, Kremer B, Hubert T, Soudan B, Lukowiak B, Vandewalle B, Vantyghem MC, Pattou F, Kerr-Conte J.

    Transplantation. 2008 Jul 27;86(2):360-3.PMID: 18645503 [PubMed - indexed for MEDLINE]Related articles

    16.

    Allosensitization of islet allograft recipients.

    Cardani R, Pileggi A, Ricordi C, Gomez C, Baidal DA, Ponte GG, Mineo D, Faradji RN, Froud T, Ciancio G, Esquenazi V, Burke GW 3rd, Selvaggi G, Miller J, Kenyon NS, Alejandro R.

    Transplantation. 2007 Dec 15;84(11):1413-27.PMID: 18091517 [PubMed - indexed for MEDLINE]Related articles

    17.

    Simple measures to monitor beta-cell mass and assess islet graft dysfunction.

    Faradji RN, Monroy K, Messinger S, Pileggi A, Froud T, Baidal DA, Cure PE, Ricordi C, Luzi L, Alejandro R.

    Am J Transplant. 2007 Feb;7(2):303-8. Epub 2006 Dec 6.PMID: 17173660 [PubMed - indexed for MEDLINE]Related articles

    18.

    Molecular mechanisms of death ligand-mediated immune modulation: a gene therapy model to prolong islet survival in type 1 diabetes.

    Sanlioglu AD, Griffith TS, Omer A, Dirice E, Sari R, Altunbas HA, Balci MK, Sanlioglu S.

    J Cell Biochem. 2008 Jun 1;104(3):710-20. Review.PMID: 18247339 [PubMed - indexed for MEDLINE]Related articles

    19.

    Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation.

    Cure P, Pileggi A, Froud T, Messinger S, Faradji RN, Baidal DA, Cardani R, Curry A, Poggioli R, Pugliese A, Betancourt A, Esquenazi V, Ciancio G, Selvaggi G, Burke GW 3rd, Ricordi C, Alejandro R.

    Transplantation. 2008 Mar 27;85(6):801-12.PMID: 18360260 [PubMed - indexed for MEDLINE]Related articles

    20.

    Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation.

    Pan H, Lu HM, Hu WM, Tian BL, Liu XB, Zhang ZD, Mai G.

    Transplant Proc. 2007 Dec;39(10):3452-4.PMID: 18089405 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity